Nusano News
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass...
Nusano’s Jzaneen Lalani Named to Top 50 Women Leaders in Healthcare Technology List
WEST VALLEY CITY, Utah – March 7, 2025 – The Healthcare Technology Report has named Jzaneen Lalani to its Top 50 Women Leaders in Healthcare Technology of 2024 list. Lalani is the Chief Business Officer (CBO) of Nusano, a physics company working to bring supply...
Nusano to Present at B. Riley Precision Oncology & Radiopharma Conference
WEST VALLEY CITY, Utah – Feb. 25, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced company management will present at the B. Riley Precision Oncology & Radiopharma Conference on Friday, Feb. 28, 2025 in New York City....
Nusano and Atomiq Collaborating to Develop Nuclear Battery Technologies
WEST VALLEY CITY, Utah – Feb. 24, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Atomiq, Inc., a cutting-edge nuclear battery technologies subsidiary of Kronos Advanced Technologies, today announced a collaboration agreement to...
Nusano Named Researcher of the Year at Inaugural Best of BioHive Awards
[dsm_image_carousel gallery_ids="292288,292284,292285,292287,292286,292280" sizes="thumbnail" lazyload="on" centered_slides="on" autoplay_speed="4000" show_lightbox="on" _builder_version="4.27.4" _module_preset="default" global_colors_info="{}"...
Nusano to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
WEST VALLEY CITY, Utah – Feb. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11,...
Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium
VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...
Nusano and Caspian Studios Announce Launch of Talk Radioisotopes Podcast
Premier episode available today across all podcast platformsVALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Caspian Studios, an award-winning content-as-a-service studio, today announced the launch of the...
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable At-211 radiopharmaceutical supplyVALENCIA, Calif. and GOTHENBURG, Sweden – Jan. 16, 2025 – Nusano, a...
Nusano Announces Isotope Availability
High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 – Nusano, a privately held physics company transforming the production of radioisotopes utilized in...
Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)
VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced it will host a virtual key opinion leader (KOL) panel discussion on Tuesday, December 17, 2024 at 1:00 PM ET to preview the year ahead in...
BLOG Posts
Nusano Named to Insights Care 5 Most Trusted Radiopharmaceutical Companies to Watch
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its "5 Most Trusted Radiopharmaceutical...
Nusano Featured in Biosphere Magazine
Nusano is featured in the 2024 edition of Biosphere magazine entitled "Profiles in Innovation." Published by BioUtah,...
MedicalXpress: Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues
From MedicalXpress: A team of researchers has developed a new method that suppresses the distribution of drugs to...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates